Bloomlife Announces FDA Clearance of Bloomlife MFM-Pro
SAN FRANCISCO, Jan. 16, 2024 /PRNewswire/ — Bloomlife, the award winning maternal health company, has received clearance from the US Food and Drug Administration (FDA) for Bloomlife MFM-Pro, their first maternal and fetal monitoring device. This announcement comes on the heels of Bloomlife’s partnership with Perigen that aims to improve essential monitoring of high-risk pregnancies.
